delta population
Showing 1 - 25 of >10,000
COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant
Not yet recruiting
- COVID-19
- High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
- +3 more
- (no location specified)
Jun 19, 2023
Early Vitrectomy for Endophthalmitis After Cataract Surgery
Completed
- Endophthalmitis
- +3 more
- Early 23-gauge pars-plana vitrectomy
-
Banhā, EgyptOphthalmology department, Benha University, EGYPT
Feb 10, 2022
COVID-19 Pandemic Trial in China (SCTV01E, Placebo (normal saline))
Recruiting
- COVID-19 Pandemic
- SCTV01E
- Placebo (normal saline)
-
Lianshui, Jiangsu, China
- +3 more
Jan 5, 2023
SARS-CoV-2 Infection, COVID-19 Trial (SCTV01E, Comirnaty)
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
- SCTV01E
- Comirnaty
- (no location specified)
Apr 11, 2022
Gastro Intestinal Bleeding, Polyps Trial in Belgium, Netherlands (NEXPOWDER-ENDOHS)
Recruiting
- Gastro Intestinal Bleeding
- Polyps
- NEXPOWDER-ENDOHS
-
Gent, Oost-Vlaanderen, Belgium
- +11 more
Oct 20, 2023
COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, mRNA vaccine manufactured by Pfizer or Moderna)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01C
- +3 more
- (no location specified)
Apr 1, 2022
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, CoronaVac, Sinopharm inactivated COVID-19 vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E
- +3 more
- (no location specified)
Apr 1, 2022
COVID-19, Sars-CoV-2 Infection Trial (SCTV01E, Comirnaty)
Not yet recruiting
- COVID-19
- Sars-CoV-2 Infection
- SCTV01E
- Comirnaty
- (no location specified)
Feb 14, 2022
COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01C
- +3 more
- (no location specified)
Apr 10, 2022
COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01C
- +3 more
- (no location specified)
Apr 1, 2022
COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, mRNA-1273)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- SCTV01E
- mRNA-1273
- (no location specified)
Apr 25, 2022
Prevalence of Acute Hepatic Porphyria
Not yet recruiting
- Acute Hepatic Porphyria
- Dosage of Delta-aminolevulinic acid and Porphobilinogen
- (no location specified)
Jun 11, 2021
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +43 more
- Best Practice
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Standardising Care for Hepatitis Delta in the Netherlands
Not yet recruiting
- Hepatitis D
- (no location specified)
Jun 6, 2023
COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)
Not yet recruiting
- COVID-19
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Placebo
- (no location specified)
Sep 22, 2023
Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant
Active, not recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
-
Wuhu, Anhui, ChinaWannan Medical College Yijishan Hospital
May 6, 2023
MIS-C and Other Complications Following SARS-CoV-2 Infection
Recruiting
- SARS CoV 2 Infection
- +3 more
-
Copenhagen, DenmarkCopenhagen University Hospital Rigshospitalet
Jun 14, 2022
Human Papillomavirus Vaccination Trial in Louise (Counseling)
Enrolling by invitation
- Human Papillomavirus Vaccination
- Counseling
-
Louise, MississippiPlan A Health, Inc
Dec 19, 2022
COVID - 19 Trial in Newcastle (TCB008)
Active, not recruiting
- COVID - 19
-
Newcastle, United KingdomRoyal Victoria Infirmary
Mar 8, 2022
Physical Activity, Sedentary Behavior, Gestational Weight Gain Trial in Jackson (Peer Health Coaching, #BabyLetsMove)
Not yet recruiting
- Physical Activity
- +3 more
- Peer Health Coaching
- #BabyLetsMove
-
Jackson, MississippiUniversity of Mississippi Medical Center
Apr 24, 2023
Retinal Disease, Healthy Population Trial in Banha (Multifocal electroretinogram (mf-ERG) by electroretinogram device)
Recruiting
- Retinal Disease
- Healthy Population
- Multifocal electroretinogram (mf-ERG) by electroretinogram device
-
Banhā, Banha, EgyptAhmed Abdelshafy Tabl
Jul 18, 2022
Testing and Epidemiology of Delta Hepatitis
Not yet recruiting
- Chronic Hepatitis D Infection With Hepatitis B
-
Los Angeles, CaliforniaAsian Pacific Liver Center
Dec 20, 2021
Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma Trial in Atlanta (Ex Vivo Expanded Allogeneic ?d T Cells in
Not yet recruiting
- Neuroblastoma
- +2 more
- Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Oct 6, 2022
Urinary Obstruction, Detrusor Underactivity Trial in Cairo (Uroflowmetry)
Completed
- Urinary Obstruction
- Detrusor Underactivity
- Uroflowmetry
-
Cairo, القاهرة, EgyptAhmed Maher
Apr 29, 2022
Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in
Completed
- COVID-19
-
Bangkok Noi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Oct 17, 2022